Metoprolol Succinate Tablet, Extended Release
Product Images NDC 63629-3286

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 63629-3286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 01)

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 01)
Chemical structure diagram of metoprolol succinate, showing the molecular components and bonding arrangement of the active ingredient in the medication.*
FDA Label Image

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 02)

Figure (0d89802b 2784 4eeb 977c 299ab20fd53e 02)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risks and 95% confidence intervals for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. It compares metoprolol succinate versus placebo across various subgroups (e.g., NYHA class, ejection fraction, ischemic etiology, sex, race, diabetes, hypertension, heart rate) with risk ratios plotted on horizontal axes for each outcome.*
FDA Label Image

Label (Lbl636293286)

Label (Lbl636293286)
Label for Metoprolol Succinate Extended-Release Tablets USP, 200 mg, repackaged by Bryant Ranch Prepack and manufactured by Zydus Lifesciences Ltd. The package contains 30 tablets. The label includes storage instructions, drug strength equivalency, and a barcode with the NDC 63629-3286-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.